Ambea Q2 net sales rise 7%, beats expectations
Swedish healthcare provider Ambea reported a 7% increase in Q2 net sales, reaching SEK 4.39 billion, surpassing analyst expectations of SEK 4.32 billion. The company's adjusted EBITA stood at SEK 397 million, and earnings per share amounted to SEK 2.13. Ambea's improved performance can be attributed to higher occupancy rates in its care units, which positively impacted both revenue and earnings.
The company's strategic expansion efforts, including new care units and acquisitions in the Nordic region, further contributed to the stronger results. Additionally, operational improvements in Norway and Denmark played a role in the positive outcome. Ambea's ongoing acquisition of Humana aims to bolster its presence in the Nordic market.
However, the company has not provided specific financial guidance for the current quarter or full year.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
